-
1 Comment
Agile Therapeutics, Inc is currently in a long term downtrend where the price is trading 47.5% below its 200 day moving average.
From a valuation standpoint, the stock is 81.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 245.3.
Agile Therapeutics, Inc's total revenue rose by inf% to $749K since the same quarter in the previous year.
Its net income has dropped by 192.6% to $-18M since the same quarter in the previous year.
Finally, its free cash flow fell by 421.2% to $-17M since the same quarter in the previous year.
Based on the above factors, Agile Therapeutics, Inc gets an overall score of 2/5.
None
Here's how to backtest a trading strategy or backtest a portfolio for AGRX using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
